Skip to content
Use caution Medical device recall · FDA · Published August 11, 2017

Invivo Xper Flex Cardio PhysioMonitoring System Recall: Intermittent Communication Hazard

Invivo recalls Xper Flex Cardio devices with intermittent communication between host system and Flex Cardio. This may cause inaccurate readings during heart and vascular monitoring. Affected models include 453564621791 and :453564621801 (Revision C).

🇺🇸 FDA recall #Z-0082-2018Medical deviceInvivo ›
Take action

Contact the company

Recalling firmInvivo Corporation12151 Research Pkwy Ste 200 · Orlando, FL 32826-3286
✎ GovInfoNow plain-language explainer

What happened, in plain English

Invivo is recalling Xper Flex Cardio physiomonitoring systems that may have intermittent communication issues between the host system and the Flex Cardio device. This could lead to inaccurate readings during heart and vascular monitoring, potentially affecting patient safety. Read more at govinfonow.com/recall/73146-invivo-xper-flex-cardio-physiomonitoring-system-recall-intermittent-communication-hazard.

Source Summary by GovInfoNow · govinfonow.com/recall/73146-invivo-xper-flex-cardio-physiomonitoring-system-recall-intermittent-communication-hazard · Updated September 18, 2026 · FDA enforcement record: FDA #Z-0082-2018

Cite this page

“Invivo Xper Flex Cardio PhysioMonitoring System Recall: Intermittent Communication Hazard.” GovInfoNow, updated September 18, 2026. https://govinfonow.com/recall/73146-invivo-xper-flex-cardio-physiomonitoring-system-recall-intermittent-communication-hazard. Based on FDA recall #Z-0082-2018 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0082-2018%22&limit=1).

Why it’s dangerous

The system may experience intermittent communication failures between the host system and the Flex Cardio device. This can cause inaccurate readings for critical heart and vascular monitoring data, which could impact patient safety if not addressed.

Who’s affected

Healthcare providers using the Xper Flex Cardio system for heart and vascular monitoring are most at risk. The system is used by physicians, nurses, and clinical technicians to analyze patient data.

How to tell if you have this one

Check for model numbers 453564621791 or 453564621801 on the device. The recall applies to all Flex Cardio devices with Revision C.

  • Brand
    Invivo
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Device Model

    Look for model numbers 453564621791 or 453564621801 on the device.

Where it went and when

Where it was distributed

Distributed in 30 states, and outside the U.S.

Alaska: yesAKMaine: not listedMEVermont: not listedVTNew Hampshire: not listedNHWashington: yesWAIdaho: yesIDMontana: not listedMTNorth Dakota: not listedNDMinnesota: not listedMNIllinois: yesILWisconsin: not listedWIMichigan: yesMINew York: yesNYRhode Island: not listedRIMassachusetts: yesMAOregon: yesORNevada: not listedNVWyoming: not listedWYSouth Dakota: yesSDIowa: yesIAIndiana: not listedINOhio: yesOHPennsylvania: yesPANew Jersey: not listedNJConnecticut: not listedCTCalifornia: yesCAUtah: not listedUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: not listedMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: not listedKSArkansas: not listedARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: not listedSCDistrict of Columbia: not listedDCOklahoma: yesOKLouisiana: yesLAMississippi: not listedMSAlabama: yesALGeorgia: yesGAHawaii: not listedHITexas: yesTXFlorida: yesFL

FDA distribution: “Worldwide Distribution - US including AK, AL, AZ, CA, CO, DE, FL, GA, IA, ID, IL, KY, LA, MA, MI, MO, NC, NE, NM, NY, OH, OR, OK, PA, SD, TN, TX, VA, WA, WV and Internationally to Germany, Hungary, India, Netherlands, Russia, Saudi Arabia,…” States read from FDA’s own wording; “not listed” means the notice does not name it.

States: Alabama, Alaska, Arizona, California, Colorado, Delaware, Florida, Georgia, Idaho, Illinois, Iowa, Kentucky, Louisiana, Massachusetts, Michigan, Missouri, Nebraska, New Mexico, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, South Dakota, Tennessee, Texas, Virginia, Washington, West Virginia.

Recall timeline

FDA terminated this recall 7.1 years after the firm started it.

1. Firm started the recall: Aug 11, 201712. FDA classified it Class II: Nov 9, 201723. Published in FDA’s Enforcement Report: Nov 15, 201734. FDA terminated the recall: Sep 20, 2024420172024
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-0082-2018 (August 11, 2017) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0082-2018 to see it in context.
  • Plain-language summary written by qwen3:4b on September 18, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA